ConductScience.org, home

Paper32905502

Organoid models of glioblastoma: advances, applications and challenges.

Zhang C and 4 others. Am J Cancer Res, 2020. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Organoid models of glioblastoma: advances, applications and challenges. Papers, record 32905502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32905502

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Organoid models of glioblastoma: advances, applications and challenges.
PubMed
Journal
Am J Cancer Res
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2020-09-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang CChaocai
2Jin MMingzhu
3Zhao JJiannong
4Chen JJuxiang
5Jin WWeilin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References110

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119398967Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche.Nat Med2009https://conductscience.org/library/papers/19398967PubMed
225957691Prospective derivation of a living organoid biobank of colorectal cancer patients.Cell2015https://conductscience.org/library/papers/25957691PubMed
328652918Engineering CAR-T cells.Biomark Res2017https://conductscience.org/library/papers/28652918PubMed
432123335Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing.Nat Cell Biol2020https://conductscience.org/library/papers/32123335PubMed
526644564Human cerebral organoids recapitulate gene expression programs of fetal neocortex development.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26644564PubMed
629788550Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization.Cancer Sci2018https://conductscience.org/library/papers/29788550PubMed
728426845HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.JAMA Oncol2017https://conductscience.org/library/papers/28426845PubMed
825533785Long-term culture of genome-stable bipotent stem cells from adult human liver.Cell2015https://conductscience.org/library/papers/25533785PubMed
931139410Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma.Clin Transl Immunology2019https://conductscience.org/library/papers/31139410PubMed
1031996670Modeling medulloblastoma in vivo and with human cerebellar organoids.Nat Commun2020https://conductscience.org/library/papers/31996670PubMed
1128697965Beyond organoids: In vitro vasculogenesis and angiogenesis using cells from mammals and zebrafish.Reprod Toxicol2017https://conductscience.org/library/papers/28697965PubMed
1232209439Organoids: A Platform Ready for Glioblastoma Precision Medicine?Trends Cancer2020https://conductscience.org/library/papers/32209439PubMed
1325043003Genome sequencing of normal cells reveals developmental lineages and mutational processes.Nature2014https://conductscience.org/library/papers/25043003PubMed
1428029927Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.N Engl J Med2016https://conductscience.org/library/papers/28029927PubMed
1532297954Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics.Neuro Oncol2020https://conductscience.org/library/papers/32297954PubMed
1627919796The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance.Pharmacol Ther2017https://conductscience.org/library/papers/27919796PubMed
1729664018Increased vessel perfusion predicts the efficacy of immune checkpoint blockade.J Clin Invest2018https://conductscience.org/library/papers/29664018PubMed
1825521283Spatially gradated hydrogel platform as a 3D engineered tumor microenvironment.Adv Mater2015https://conductscience.org/library/papers/25521283PubMed
1926806352A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.Neoplasia2016https://conductscience.org/library/papers/26806352PubMed
2026896279A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.Cancer Res2016https://conductscience.org/library/papers/26896279PubMed

See all 110 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42693244Integrating ex vivo platforms with AI to guide glioblastoma treatment.J Neurooncol2026https://conductscience.org/library/papers/42693244PubMed
42218467Organoids as next-generation models for investigating intracranial tumours.Mol Brain2026https://conductscience.org/library/papers/42218467PubMed
41993610Translational Models for Glioblastoma: Revolutionizing Drug Development and Personalized Medicine through Clinical Insights.Theranostics2026https://conductscience.org/library/papers/41993610PubMed
41789657Cellular and inflammatory characteristics of patient‑derived glioblastoma organoids during in vitro cultivation.Oncol Rep2026https://conductscience.org/library/papers/41789657PubMed
41226697Modeling Glioblastoma with Brain Organoids: New Frontiers in Oncology and Space Research.Int J Mol Sci2025https://conductscience.org/library/papers/41226697PubMed
40548110Development and validation of a deep learning algorithm for discriminating glioma recurrence from radiation necrosis on MRI.Front Oncol2025https://conductscience.org/library/papers/40548110PubMed
40183896Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening.Curr Oncol Rep2025https://conductscience.org/library/papers/40183896PubMed
39963753Targeting PGE2 mediated senescent neuron improves tumor therapy.Neuro Oncol2025https://conductscience.org/library/papers/39963753PubMed
39813590Engineered Cell Microenvironments: A Benchmark Tool for Radiobiology.ACS Appl Mater Interfaces2025https://conductscience.org/library/papers/39813590PubMed
39553223Generation and banking of patient-derived glioblastoma organoid and its application in cancer neuroscience.Am J Cancer Res2024https://conductscience.org/library/papers/39553223PubMed
39292297A reference for selecting an appropriate method for generating glioblastoma organoids from the application perspective.Discov Oncol2024https://conductscience.org/library/papers/39292297PubMed
39240627Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements.Cancer Biomark2024https://conductscience.org/library/papers/39240627PubMed
39185670Microbiota and glioma: a new perspective from association to clinical translation.Gut Microbes2024https://conductscience.org/library/papers/39185670PubMed
38474286Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.Int J Mol Sci2024https://conductscience.org/library/papers/38474286PubMed
38435477Personalized Medicine in Brain Gliomas: Targeted Therapy, Patient-Derived Tumor Models (Review).Sovrem Tekhnologii Med2023https://conductscience.org/library/papers/38435477PubMed
38394389A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth.Adv Healthc Mater2024https://conductscience.org/library/papers/38394389PubMed
38017433Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.Mol Cancer2023https://conductscience.org/library/papers/38017433PubMed
37928397Non-animal glioblastoma models for personalized treatment.Heliyon2023https://conductscience.org/library/papers/37928397PubMed
37901257Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy.RSC Adv2023https://conductscience.org/library/papers/37901257PubMed
37389023Development of a 3D Tumor Spheroid Model from the Patient's Glioblastoma Cells and Its Study by Metabolic Fluorescence Lifetime Imaging.Sovrem Tekhnologii Med2023https://conductscience.org/library/papers/37389023PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32905502

GET https://conductscience.org/api/papers/v1/32905502/references?page=2